Steroid sparing
Showing 1 - 25 of 2,981
Chemo-induced Nausea and Vomiting Trial in Sayre (OLA group: Olanzapine, DEX group: Dexamethasone)
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- OLA group: Olanzapine
- DEX group: Dexamethasone
-
Sayre, PennsylvaniaRobert Packer Hospital
Jan 12, 2023
Hepatitis Immune Trial (Active Surveillance, Early initiation)
Not yet recruiting
- Hepatitis Immune
- Active Surveillance
- Early initiation
- (no location specified)
Jul 14, 2022
Multiple Myeloma Trial in Rochester (Daratumumab, Lenalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Daratumumab
- +2 more
-
Rochester, New YorkUniversity of Rochester Medical Center
Jul 8, 2022
Extra Pulmonary Sarcoidosis Trial in France (Hydroxychloroquine, Placebo)
Not yet recruiting
- Extra Pulmonary Sarcoidosis
- Hydroxychloroquine
- Placebo
-
Avignon, France
- +13 more
Apr 24, 2023
CTCL Trial in New York (StrataCTX® gel)
Recruiting
- CTCL
- StrataCTX® gel
-
New York, New YorkColumbia University Medical Center, Department of Dermatology
Aug 3, 2021
Diabetes Type 1 Trial run by the NIDDK (Islet Transplantation)
Completed
- Diabetes Mellitus Type 1
- Islet Transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 19, 2021
Steroid Dependent Crohn's Disease Trial in Beer Sheva, Kfar Saba, Tzrifin (Cannabidiol , synthetic form, Placebo)
Unknown status
- Steroid Dependent Crohn's Disease
- Cannabidiol , synthetic form
- Placebo
-
Beer Sheva, Israel
- +2 more
Jun 29, 2020
Autoimmune Hepatitis Trial in Petach Tikva (Cannabidiol)
Terminated
- Autoimmune Hepatitis
-
Petach Tikva, IsraelBelinson Medical Center
Jun 14, 2020
CNI Side Effects Trial in Minneapolis (Cyclosporine & Cellcept, Prograf & Cellcept, Low Dose CNI (Cyclosporine or FK) and
Completed
- CNI Side Effects
- Cyclosporine & Cellcept
- +3 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Nov 17, 2020
Asthma, Allergic Rhinitis Trial in Dundee (Fluticasone Evohaler pMDI, Placebo, Fluticasone Evohaler)
Completed
- Asthma
- Allergic Rhinitis
- Fluticasone Evohaler pMDI
- +4 more
-
Dundee, Angus, United KingdomAsthma and Allergy Research Group, Ninewells Hospital and Univer
Oct 10, 2019
Steroid-Dependent Nephrotic Syndrome, Steroid-Sensitive Nephrotic Syndrome Trial in Paris (single infusion of Rituximab, single
Not yet recruiting
- Steroid-Dependent Nephrotic Syndrome
- Steroid-Sensitive Nephrotic Syndrome
- single infusion of Rituximab
- single infusion of Obinutuzumab
-
Paris, FranceRobert Debre Hospital
Mar 14, 2023
Systemic Lupus Erythematosus (SLE), Repository Corticotropin Injection Trial (Acthar low dose (40 U), Acthar high dose (80 U))
Withdrawn
- Systemic Lupus Erythematosus (SLE)
- Repository Corticotropin Injection
- Acthar low dose (40 U)
- Acthar high dose (80 U)
- (no location specified)
Sep 11, 2019
First Manifestation of Steroid Sensitive Nephrotic Syndrome Trial in Paris (Levamisole Hydrochloride, Placebo)
Completed
- First Manifestation of Steroid Sensitive Nephrotic Syndrome
- Levamisole Hydrochloride
- Placebo
-
Paris, FranceHôpital Robert Debré
Jun 7, 2022
Nephrotic Syndrome Steroid-Dependent Trial in Genova (Rituximab Biosimilar)
Recruiting
- Nephrotic Syndrome Steroid-Dependent
- Rituximab Biosimilar
-
Genova, ItalyIRCCS G. Gaslini
Dec 19, 2022
Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
Recruiting
- Polymyalgia Rheumatica (PMR)
- Giant Cell Arteritis (GCA)
- Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness)
- +3 more
-
Basel, SwitzerlandDepartment of Rheumatology University Hospital Basel
Aug 2, 2022
Steroid-Dependent Nephrotic Syndrome Trial in Kolkata (Rituximab, Mycophenolate Mofetil)
Active, not recruiting
- Steroid-Dependent Nephrotic Syndrome
- Rituximab
- Mycophenolate Mofetil
-
Kolkata, West Bengal, IndiaNilratan Sircar Medical College and Hospital
Apr 6, 2022
Uveitis Trial in Worldwide (Mycophenolate mofetil, Methotrexate, Prednisone)
Completed
- Uveitis
- Mycophenolate mofetil
- +2 more
-
San Francisco, California
- +8 more
Oct 16, 2019
ECP Combination Study
Active, not recruiting
- Steroid Refractory GVHD
- Ruxolitinib
- +2 more
-
Antwerp, Belgium
- +37 more
Jun 17, 2022
Uveitis, Scleritis Trial in Saint Louis (tofacitinib)
Unknown status
- Uveitis
- Scleritis
-
Saint Louis, MissouriWashington University in Saint Louis
Jan 7, 2021
Distal Radius Fracture Trial in Germantown (Opiate Sparing, Opiate Based)
Enrolling by invitation
- Distal Radius Fracture
- Opiate Sparing
- Opiate Based
-
Germantown, TennesseeCampbell Clinic
Jun 28, 2022
Atopic Dermatitis Trial in Dublin (DS107E, Vehicle, Hydrocortisone Butyrate 0.1% Cream)
Completed
- Atopic Dermatitis
- DS107E
- +2 more
-
Dublin, IrelandDS Biopharma Investigational Site
Feb 6, 2019
Cutaneous Lupus, Systemic Lupus Erythematosus Trial in Cincinnati, Cleveland (Tofacitinib)
Completed
- Cutaneous Lupus
- Systemic Lupus Erythematosus
-
Cincinnati, Ohio
- +1 more
Dec 19, 2022